Tae Min Kim, MD, PhD^1*, Nehal Lakhani, MD, PhD^2*, Justin Gainor, MD^3*, Manali Kamdar, MD⁴, Philip Fanning, PhD^5*, Pierre Squifflet, MSc^6*, Feng Jin, PhD^5*, Alison J. Forgie, PhD^5*, Hong Wan, PhD^5*, Jaume Pons, PhD^5*, Sophia S Randolph, MD, PhD⁵ and Won Seog Kim, MD, PhD^7*

¹Seoul National University Hospital, Seoul, South Korea
²START Midwest, Grand Rapids, MI
³Massachusetts General Hospital Cancer Center, Boston, MA
⁴Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Denver, CO
⁵ALX Oncology Inc., Burlingame, CA
⁶International Drug Development Institute, Ottignies Louvain-la-Neuve, BEL
⁷Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Dok Hyun Yoon^1*, Youngil Koh, MD, PhD², Heesook Park^3*, Yu kyeong Hwang^4* and Won Seog Kim^5*

¹Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
²Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
³Development Unit, Cell Therapy Research Center, GCLabCell, Yongin-Si, Gyeonggi-Do, South Korea
⁴Cell Therapy Research Center, GCLabCell, Yongin, Korea, Republic of (South)
⁵Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Khe Hoang-Xuan, MD, PhD^1*, Roch Houot, MD, PhD^2*, Carole Soussain, MD, PhD³, Marie Blonski, MD^4*, Anna Schmitt, MD^5*, Vincent Delwail, MD^6*, Gandhi Laurent Damaj, MD, PhD⁷, Herve Ghesquieres, MD, PhD^8*, Frédéric Peyrade, MD^9*, Adrian Tempescul, MD^10*, Julie Abraham, MD^11*, Philippe Agape, MD^12*, Guido Ahle, MD^13*, Nathalie Baize, MD^14*, Pierre Bories, MD^15*, Chantal Campello, MD^16*, Emmanuel Gyan, MD, PhD¹⁷, Fabrice Jardin, MD, PhD^18*, Philippe Rey, MD^19*, Sylvain Choquet, MD^20*, Caroline Houillier, MD^21*, Nathalie Cassoux, MD, PhD^22*, Valerie Touitou, MD, PhD^23*, Nadine Martin-Duverneuil, MD^24*, Frederic Legrand^25*, Assia Lamrani-Ghaouti^26*, Ophelie Querel^26*, Natalie Hoog Labouret, MD^25*, Clotilde Simon^26*, Sylvie Chevret, MD, PhD^27* and Christophe Massard, MD, PhD^28*

¹Department of Neurooncology, La Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Paris, France
²Hematology Department, CHU Rennes, Rennes, France
³Hematology Department, Rene Huguenin Hospital, Institut Curie, Saint-Cloud, France
⁴CHU Nancy, Nancy, France
⁵Institut Bergonié, Bordeaux, France
⁶CIC 802 INSERM, CHU Poitiers, Poitiers, FRA
⁷CHU de Caen Normandie, Normandie, France
⁸Department of Hematology, Centre Hospitalier Lyon-Sud, University Claude Bernard Lyon 1, Pierre Benite, France
⁹Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France
¹⁰Department of Hematology, University Hospital of Brest, Brest, France
¹¹Clinical Hematology Service, CHU Limoges, Limoges, FRA
¹²Hematology Department, ICO Rene Gauducheau, Saint-Herblain, France
¹³Neurology Department, CH Colmar, Colmar, France
¹⁴CHU Angers, Angers, France
¹⁵Hematology Laboratory, Onco-occitanie Network, Toulouse University Institute of Cancer-Oncopole, Toulouse, France
¹⁶CHU Marseille, Neurooncology Unit ,Hôpital La Timone, Marseille, France
¹⁷Centre Hospitalier Universitaire, Service D'Hemaologie Et Therapie Cellulaire, Tours Cedex, France
¹⁸Department of Hematology, Centre Henri Becquerel, Rouen, France
¹⁹Hematology, Centre Leon Berard, Lyon, France
²⁰Hematology Department, La Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Paris, France
²¹LOC network, La Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Paris, France
²²Institut Curie, Paris, FRA
²³Department of Ophtalmology, AP-HP, HôPital Pitié-Salpêtrière, Paris, FRA
²⁴Department of Neuroradiology, APHP, CHU Pitié-Salpêtrière, Paris, France
²⁵Inca, Boulogne Billancourt, France
²⁶Unicancer, Paris, France
²⁷APHP, HOPITAL St LOUIS, PARIS, France
²⁸Gustave Roussy Cancer Campus, Villejuif, France

Beatriz Rey Búa^1*, Ana Jiménez Ubieto, MD PhD^2*, Jose Javier Sanchez Blanco^3*, Pau Abrisqueta, MD, PhD^4*, Antonio Gutierrez^5*, Angel Ramirez Payer^6*, Eva Giné, MD, PhD⁷, Izaskun Cebeiro Sr.^8*, Maria Jose Terol^9*, Fatima De la Cruz, MD^10*, Rafael Andreu^11*, María José Ramírez Sánchez^12*, Adolfo de la Fuente^13*, Ma Cruz Viguria^14*, Maria Jesús Peñarrubia^15*, Carlos Grande^16*, Dolores Caballero, MD, PhD¹⁷ and Alejandro Martin Garcia-Sancho, MD, PhD^18*

¹Hospital Universitario de Salamanca Hematología. Instituto de investigación biomédica de Salamanca (IBSAL), Salamanca, Spain
²Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain
³Hospital Morales Messeguer, Murcia, Spain
⁴Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
⁵Hematology Department, Son Espases University Hospital/IdISBa, Palma, Spain
⁶H. C. Asturias, Oviedo, Asturias, Spain
⁷Hematology Department, Hospital Clinic of Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
⁸H. de Donostia, Donostia, Donostia, Spain
⁹Hospital Clínico Universitari de València, Valencia, Spain
¹⁰Hospital Universitario Virgen del Rocio, Seville, ESP
¹¹Hospital Universitario La Fe de Valencia, VALENCIA, ESP
¹²H. Especialidades Jerez de la Frontera, Jerez, Jerez, Spain
¹³MD Anderson Cancer Center, Madrid, Spain
¹⁴Complejo Hospitalario de Navarra, Navarra, Spain
¹⁵Hospital Clinico Universitario de Valladolid, Valladolid, Spain
¹⁶Hospital 12 De Octubre, Madrid, ESP
¹⁷Department of Hematology, Hospitalario Universitario de Salamanca (HUS/IBSAL) and CIBERONC, Salamanca, Spain
¹⁸Department of Hematology, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain

Laurie H. Sehn, MD, MPH¹, Mark Hertzberg^2*, Stephen Opat, MBBS (Hons), FRACP, FRCPA³, Alex F. Herrera, MD⁴, Sarit E Assouline, MD, MSc⁵, Christopher Flowers, MD, MS⁶, Tae Min Kim, MD, PhD^7*, Andrew McMillan⁸, Muhit Ozcan, MD⁹, Violaine Safar^10*, Gilles Salles, MD, PhD¹⁰, Lisa Musick, PharmD, BCPS^11*, Jamie Hirata¹², YiMeng Chang^13*, Grace Ku^12* and Matthew J Matasar, MD, MS¹⁴

¹BC Cancer Centre for Lymphoid Cancer, University of British Columbia, vancouver, BC, Canada
²Prince of Wales Hospital and University of NSW, Sydney, Australia
³Clinical Haematology, Monash Health and Monash University, Clayton, Australia
⁴City of Hope, Duarte, CA
⁵Division of Hematology, Sir Mortimer B. Davis-Jewish General Hospital, Department of Oncology, McGill University, Montreal, QC, Canada
⁶MD Anderson Cancer Center, Houston, TX
⁷Seoul National University Hospital, Seoul, South Korea
⁸Center for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⁹Ankara University School of Medicine, Ankara, Turkey
¹⁰Centre Hospitalier Lyon-Sud, Lyon, France
¹¹Genentech, South San Francisco, CA
¹²Genentech, Inc., South San Francisco, CA
¹³F. Hoffmann-La Roche Ltd, Mississauga, ON, Canada
¹⁴Department of Medicine, Lymphoma Service, Memorial Sloan-Kettering Cancer Center/New York Presbyterian, New York, NY

Kami J. Maddocks, MD¹, Johannes Duell, MD^2*, Eva González-Barca, MD, PhD^3*, Wojciech Jurczak^4*, Anna Marina Liberati, MD⁵, Sven de Vos, MD, PhD⁶, Zsolt Nagy, MD, PhD^7*, Aleš Obr, MD, PhD^8*, Gianluca Gaidano⁹, Pau Abrisqueta, MD, PhD^10*, Marc André, MD^11*, Martin Dreyling, MD¹², Tobias F Menne, MD, PhD, FRCPath^13*, Maren Dirnberger-Hertweck, PhD^14*, Johannes Weirather, PhD^14*, Sumeet Ambarkhane, MD, MBBS¹⁴ and Gilles Salles, MD, PhD¹⁵

¹Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH
²Medizinische Klinik und Poliklinik II, Universitätsklinik Würzburg, Würzburg, Germany
³Department of Hematology, Institut Catalá d’Oncologia (ICO), Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain
⁴Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland
⁵Università degli Studi di Perugia, Azienda Ospedaliera Santa Maria di Terni, Terni, Italy
⁶Department of Medicine, Ronald Reagan UCLA Medical Center, Santa Monica, CA
⁷1st Department of Internal Medicine, Semmelweis University, Budapest, Hungary
⁸Department of Hemato-Oncology, Palacký University and University Hospital, Olomouc, Czech Republic
⁹Division of Hematology, Department of Translational Medicine, University of Piemonte Orientale Amedeo Avogadro, Novara, Italy
¹⁰Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain
¹¹Department of Haematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium
¹²LMU Hospital, Munich, Germany
¹³Department of Haematology, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom
¹⁴MorphoSys AG, Planegg, Germany
¹⁵Hématologie, Hospices Civils de Lyon and Université de Lyon, Lyon, France

Jie Wang, MD¹, Adam S. Asch, MD², Nada Hamad, MBBS, BSc, MSc, FRACP FRCPA³, Andrew Weickhardt, MBBS(Hons) FRACP DMedSc^4*, Monika Tomaszewska-Kiecana^5*, Monika Dlugosz-Danecka, MD, PhD^6*, Halyna Pylypenko, MD^7*, Shakeela Bahadur, MD^8*, Susanna Ulahannan, MD, MMed^9*, Janine Koucheki^10*, Jichao Sun, PhD^10*, Hua Li^10*, Francine Chen, MD^11*, Xiaoyu Zhang^10*, John Muth, MS^10*, Patrick Kaminker, PhD^10*, Paul Moore, PhD^10* and Bradley James Sumrow, MD^10*

¹Duke Cancer Institute, Durham, NC
²Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK
³Department of Haematology, St Vincent's Hospital, Sydney, Australia
⁴Austin Health, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
⁵BioVirtus, Jozefow, Poland
⁶Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
⁷Regional Treatment and Diagnostics Haematology Centre, Department of Hematology, Cherkasy Regional Oncology Centre, Cherkasy, Ukraine
⁸Banner MD Anderson Cancer Center, Gilbert, AZ
⁹University of Oklahoma Health Sciences Center, Oklahoma City, OK
¹⁰MacroGenics, Inc., Rockville, MD
¹¹MacroGenics, Inc., Brisbane, CA

Sophie Bernard^1*, Hervé Ghesquieres, MD, PhD^2*, Rene-Olivier Casasnovas, MD^3,4*, Maria Gomes Da Silva, MD, PhD^5*, Pierre Feugier, MD, PhD^6*, Franck Morschhauser, MD, PhD^7*, Judith Trotman, FRACP⁸, Richard Greil, MD⁹, Dolores Caballero, MD, PhD¹⁰, Sebastian Grosicki, MD, PhD¹¹, Koen Van Eygen, MD^12*, Christiane Copie, MD PhD^13*, Corinne Haioun, MD PhD¹⁴ and Catherine Thieblemont, MD, PhD¹⁵

¹Assistance Publique Hôpitaux de Paris - Hopital Saint-Louis, Paris, Paris, France
²Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France
³Hématologie Clinique and INSERM 1231, CHU Dijon, Dijon, France
⁴Inserm UMR 1231, Dijon, France
⁵IPO, Lisboa, Portugal
⁶Hematology Department, Nancy University Hospital, Vandoeuvre-lès-Nancy, France
⁷Clinical Hematology Department, Centre Hospitalier Régional Universitaire de Lille, Lille, France
⁸Haematology, Concord Repatriation General Hospital, University of Sydney, Concord, Australia
⁹Salzburg Cancer Research Institute CCCIT, Cancer Cluster Salzburg, Paracelsus Medical University Salzburg, Salzburg, Austria
¹⁰Hospital Universitario de Salamanca, Salamanca, Spain
¹¹Department of Hematology and Cancer Prevention, Medical University of Silesia, Katowice, Poland
¹²Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium
¹³Department of Pathology, CHU Henri Mondor, AP HP, Paris, France
¹⁴Lymphoid Malignancies, Henri Mondor Hospital, Creteil, France
¹⁵APHP, Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris Diderot, Paris, France

Peter Hillmen, MBChB, PhD, FRCP, FRCPath¹, Hope Qamoos, CNP^2*, Anne Uyei, MD^2*, Wayne M. Rothbaum^2*, Wojciech Jurczak, MD, PhD³, Catherine Thieblemont, MD, PhD⁴ and John C. Byrd, MD⁵

¹St. James's University Hospital, Leeds, United Kingdom
²Kartos Therapeutics, Inc., Redwood City, CA
³Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
⁴Hôpital Saint-Louis, Paris, France
⁵The James - Ohio State University, Columbus, OH

Jillian Simard, MD¹, Christopher Melani, MD², Rahul Lakhotia, MD¹, Michail S. Lionakis, MD, ScD^3*, Stefania Pittaluga, MD, PhD⁴, James D. Phelan, PhD^1*, Jagan R. Muppidi, MD, PhD^1*, Lydia L. Chou, CRNP^1*, Matthias Holdhoff, MD, PhD^5*, Michael Glantz, MD, PhD^6*, John A. Butman, MD, PhD^7*, Andrea Nicole Lucas, RN^1*, Seth M. Steinberg, PhD^8*, Elaine S. Jaffe, MD⁴, Louis M. Staudt, MD, PhD¹, Wyndham H. Wilson, MD, PhD¹ and Mark Roschewski, MD⁹

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Baltimore, MD
³Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
⁴Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁵Department of Neuro-Oncology, Johns Hopkins Cancer Center, Baltimore, MD
⁶Department of Neurosurgery, Penn State College of Medicine, Hershey, PA
⁷Radiology and Imaging Sciences, Clinical Center, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁸Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Colin Phipps, MD^1,2*, Chandramouli Nagarajan, MBBS^1*, Lawrence Ng, MBBS^1*, Jane L Chua^1*, Yunxin Chen, MBBS^1*, Shin Yeu Ong, MD^1*, Melinda Si Yun Tan, MBBS^1*, Nicholas Francis Grigoropoulos, MD, PhD^1*, Sathish Gopalakrishnan, MD^1,3*, Heng Joo Ng, MBBS^1*, William YK Hwang, MBBS^1,4, Yeow Tee Goh, MBBS¹ and Yuh Shan Lee, MBBS^1,2*

¹Department of Hematology, Singapore General Hospital, Singapore, Singapore
²Parkway Cancer Centre, Singapore, Singapore
³Hematology, Northeast Cancer Centre, Sudbury, Canada
⁴National Cancer Center Singapore, Singapore, Singapore

Ulrich Jaeger, MD^1,2, Alexander Egle, MD³, Ingrid Simonitsch-Klupp, MD^4*, Sonja Heibl, MD^5*, Peter Neumeister, MD^6*, Ella Willenbacher, MD⁷, Florian Erlsbacher^8*, Julian Larcher-Senn^8*, Michael A. Fridrik, MD⁹ and Richard Greil, MD^2,3

¹Department of Medicine I, Division of Hematology and Hemostaseology, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
²Austrian Group Medical Tumor Therapy, Salzburg, Austria
³Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria
⁴Department of Pathology, Medical University of Vienna, Vienna, Austria
⁵Dept. of Internal Medicine IV, Klinikum Wels-Grieskirchen GmbH, Wels, Austria
⁶Department of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria
⁷Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria
⁸Assign Data Management and Biostatistics GmbH, Innsbruck, Austria
⁹Department of Hematology and Oncology, Kepler University Hospital, Johannes Kepler University, Linz, Austria

David Belada, MD, PhD^1*, Grzegorz S. Nowakowski, MD², Juan Miguel Bergua Burgues, MD^3*, Marc André, MD^4*, Katerina Kopeckova, MD^5*, Don A. Stevens, MD⁶, Marek Trněný, MD, Prof⁷, Ernesto Pérez Persona^8*, Petra Pichler^9*, Pia Klöpfer^10*, Bettina Brackertz^10*, Emanuel Lohrmann, MD^10*, Anirban Lahiry^10*, Neha Shah^10*, Günter Fingerle-Rowson, MD, PhD¹⁰, Wolfram Brugger^10* and John M. Burke, MD¹¹

¹4th Department of Internal Medicine – Hematology, University, Hospital and Faculty of Medicine, Hradec Králové, Czech Republic
²Division of Hematology, Mayo Clinic, Rochester, MN
³Hematology, Hospital San Pedro Alcántara, Caceres, Spain
⁴Department of Haematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium
⁵Fakultni nemocnice v Motole, Prague, Czech Republic
⁶Norton Cancer Institute - St Matthews Campus, Louisville, KY
⁷1st Dept. of Internal Medicine, First Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic
⁸Hospital Universitario Araba, Txagorritxu, Spain
⁹9Department of Internal Medicine, University Hospital of St Pölten, Karl Landsteiner University of Health Sciences, Karl Landsteiner Institute for Nephrology and Hemato Oncology, St Pölten, Austria
¹⁰MorphoSys AG, Planegg, Germany
¹¹US Oncology Hematology Research Program, US Oncology Research and Rocky Mountain Cancer Centers, Aurora, CO

Tae Min Kim, MD, PhD^1*, Arancha Alonso, MD^2*, Miles Prince, MD³, Michal Taszner, MD^4*, Seok-Goo Cho, M.D., Ph.D.^5*, Don A. Stevens, MD⁶, Michelle Poon, MD^7*, Francesca Lim, MBBS, BSc, MRCP (UK)^8*, Steven Le Gouill, MD, PhD⁹, Cecilia Carpio, MD^10,11*, Mary-Margaret Keating, MD, FRCPC¹², Lieve Adriaens, PharmD^13*, Melanie Ufkin, PhD¹³, Ayesha Sabir, BSc^13*, Jingjin Li, PhD^13*, Vladimir Jankovic, MD¹³, Min Zhu, PhD^13*, Jurriaan Brouwer-Visser, PhD^13*, Siyang Leng, MD, MS^13*, L. Andres Sirulnik, MD, PhD¹³, Aafia Chaudhry, MD, MBA, MS^13*, Srikanth R. Ambati, MBBS, MD^13* and Kim Won Seog, MD, PhD^14*

¹Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
²Hospital Universitario Quirón Salud, Madrid, Spain
³Cancer Immunology and Molecular Oncology, Epworth Healthcare, University of Melbourne, Melbourne, Australia
⁴Hematology and Bone Marrow Transplantation Department, University of Gdańsk, Gdańsk, Poland
⁵Department of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁶Norton Health Care, Louisville, KY
⁷Department of Haematology-Oncology, National University Hospital, Singapore, Singapore
⁸Department of Haematology, Singapore General Hospital, Singapore, Singapore
⁹Service d'hématologie clinique, CHU de Nantes, Nantes, France
¹⁰Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
¹¹Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain
¹²Dalhousie University, Halifax, NS, Canada
¹³Regeneron Pharmaceuticals, Inc., Tarrytown, NY
¹⁴Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Nirav N. Shah, MD¹, Ahmad H. Mattour, MD², Leslie L. Popplewell, MD, FACP³, Charalambos Andreadis, MD⁴, Jason M. Melear, MD⁵, Alexander I. Spira, PhD, MD, FACP^6*, Jonah Shulman, MD^7*, Sudhir Manda, MD⁸, John M. Burke, MD⁹, Saurabh Chhabra, MD, MS¹, Jeff P Sharman, MD¹⁰, Amrita Krishnan, MD³, Nina Shah, MD¹¹, Clifford DiLea, RPh, Pharm.D.^12*, Jason Kuriakose, MBA^13*, Craig Jerome Berman, MD^13*, Shannon L. Matheny, PhD^13*, John P. Leonard, MD¹⁴ and Arturo Molina, MD, MS¹³

¹Medical College of Wisconsin, Milwaukee, WI
²Henry Ford Health System, Detroit, MI
³City of Hope, Duarte, CA
⁴University of California, San Francisco, San Francisco, CA
⁵Texas Oncology, Austin, TX
⁶Virginia Cancer Specialists, Fairfax, VA
⁷Icahn School of Medicine at Mount Sinai, New York, NY
⁸Arizona Oncology/US Oncology Research, Tucson, AZ
⁹Rocky Mountain Cancer Centers, Aurora, CO
¹⁰Willamette Valley Cancer Institute and Research Center, Eugene, OR
¹¹Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
¹²Aclairo Pharmaceutical Development Group, Inc., Vienna, VA
¹³Sutro Biopharma, South San Francisco, CA
¹⁴Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY

Reem Karmali, MD, MSc¹, Jeremy S Abramson, MD, MMSc², Deborah M. Stephens, DO³, Jeffrey A Barnes, MD, PhD², Jason Kaplan, MD⁴, Jane N. Winter, MD⁵, Shuo Ma, MD, PhD⁶, Juehua Gao, MD, PhD^7*, Adam M Petrich, MD^8,9, Ephraim Hochberg, MD², Ronald Takvorian^10*, Frank Kuhr, PhD^11*, Valerie Nelson, MD, MBA^6*, Leo I. Gordon, MD⁶ and Barbara Pro, MD¹²

¹Robert H. Lurie Comprehensive Cancer Center, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL
²Massachusetts General Hospital Cancer Center, Boston, MA
³University of Utah/Huntsman Cancer Institute, Salt Lake City, UT
⁴Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
⁵Division of Hematology and Oncology, Northwestern University, Chicago, IL
⁶Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
⁷Department of Pathology, Northwestern University, Chicago, IL
⁸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁹Daiichi-Sankyo, Inc., Basking Ridge, NJ
¹⁰Massachusetts General Hospital, Harvard Medical School, Boston, MA
¹¹Adaptive Biotechnologies, Seattle, WA
¹²Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

Lorenz Thurner, MD^1*, Viola Poeschel, MD^2*, Bettina Altmann, PhD^3*, Herve Tilly, MD, PhD⁴, Marc Andre, MD^5*, Marie Maerevoet, MD^6*, Thomas Weber, MD^7*, Joerg Hoffmann, MD^8*, Martin Dreyling, MD⁹, Herve Maisonneuve, MD¹⁰, Andrea Kerkhoff, MD^11*, Steven Le Gouill, MD, PhD¹², Stephan Stilgenbauer, MD¹³, Marita Ziepert, PhD^3*, Roch Houot, MD, PhD^14*, Corinne Haioun, MD PhD¹⁵ and Gerhard Held, MD^16*

¹Department of Hematology, Oncology, Rheumatology and Clinical Immunology, Saarland University Medical Center, Homburg, Germany
²Department of hematology, oncology and rheumatology, Saarland University Medical School, Homburg/Saar, Germany
³Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, IMISE, Leipzig, Germany
⁴Centre Henri Becquerel, Rouen, France
⁵Hematology Department, Hopital Charleroi, Charleroi, BEL
⁶Department of Hematology, Institut Jules Bordet (ULB), Brussels, Belgium
⁷Department of Medicine IV, Hematology and Oncology, University Hospital Halle, Halle, DEU
⁸Hämatologie, Onkologie und Immunologie, Philipps Universität Marburg, Marburg, Germany
⁹Department of Medicine III, Klinikum Der Universitaet Muenchen-Campus Grosshadern, Munich, Germany
¹⁰Clinical Hematology, Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France
¹¹Department of Medicine A, University Hospital Muenster, Muenster, Germany
¹²Service d'hématologie clinique, CHU de Nantes, Nantes, France
¹³Department of Internal Medicine I, Saarland University Medical School, Homburg, Germany
¹⁴Hematology Department, CHU Rennes, Rennes, France
¹⁵Clinical Hematology, Henri Mondor University Hospital, UPEC, Creteil, France
¹⁶Department for hematology and oncology, Westpfalz-Klinikum Kaiserslautern, Kaiserslautern, Germany

Karin Fjorden^1*, Sara Ekberg^2*, Nevzeta Kuric^3*, Karin Ekstroem Smedby^4*, Ingemar Lagerlöf, MD^5*, Thomas S. Larsen, MD^6*, Judit M. Jørgensen, MD, PhD^7*, Peter de Nully Brown, MD, PhD^8* and Mats Jerkeman, MD, PhD¹

¹Department of Oncology, Lund University and Skane University Hospital, Lund, Sweden
²Division of Clinical Epidemiology, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
³Department of Hematology, Halmstad Hospital, Halmstad, Sweden
⁴Department of Medicine, Solna, Division of Hematology, Karolinska Institute and Karolinska University Hospital, Stockholm, Stockholm, Sweden
⁵Division of Drug Research, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
⁶Department of Hematology, Odense University Hospital, Odense, Denmark
⁷Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
⁸Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Neil Bailey, MSc^1*, Tenzin Tsomo, BS^1*, Jennie Szeto, BA^1*, William I Bensinger, MD^1*, Daniel Egan, MD^2*, Livia Hegerova, MD^2*, Raya Mawad, MD^3*, Ami Batchelder, PA^2*, Joanna Fesler, ARNP^1*, Heather Holdread, MS, NP^2*, Sonia Glennie, ARNP^1*, Judson Hall, ARNP^2*, Joey Ferry, ARNP^2*, Megumi Bailey, MSc^4*, David Kane, RN^2*, John M. Pagel, MD PhD¹ and Krish Patel, MD¹

¹Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
²Swedish Medical Center, seattle
³Swedish Cancer Institute, Seattle, WA
⁴Swedish Medical Center, Seattle, WA